Drug Safety

Safety Profile of the Respiratory Fluoroquinolone Moxifloxacin: Comparison with Other Fluoroquinolones and Other Antibacterial Classes
pp. 359-378(20)
Authors: >Françoise Van Bambeke,; Tulkens, Paul M.

Prevalence, Incidence and Nature of Prescribing Errors in Hospital Inpatients: A Systematic Review
pp. 379-389(11)
Authors: Lewis, Penny J.; Dornan, Tim; Taylor, David; Tully, Mary P.; Wass, Val; Ashcroft, Darren M.

Patch Testing for the Diagnosis of Anticonvulsant Hypersensitivity Syndrome: A Systematic Review
pp. 391-408(18)
Authors: Elzagallaai, Abdelbaset A.; Knowles, Sandra R.; Rieder, Michael J.; Bend, John R.; Shear, Neil H.; Koren, Gideon

Hypoglycaemia with Oral Antidiabetic Drugs: Results from Prescription-Event Monitoring Cohorts of Rosiglitazone, Pioglitazone, Nateglinide and Repaglinide
pp. 409-418(10)
Authors: Vlckova, Veronika; Cornelius, Victoria; Kasliwal, Rachna; Wilton, Lynda; Shakir, Saad A.W.

Data Mining in Pharmacovigilance - Detecting the Unexpected: The Role of Index of Suspicion of the Reporter
pp. 419-427(9)
Authors: Sundström, Anders; Hallberg, Pär

Avoidability of Adverse Drug Reactions Spontaneously Reported to a French Regional Drug Monitoring Centre
pp. 429-440(12)
Authors: >Annie Pierre Jonville-Béra,; Saissi, Hassan; Bensouda-Grimaldi, Lamiae; Beau-Salinas, Frederique; Cissoko, Haware; Giraudeau, Bruno; Autret-Leca, Elisabeth

Effect of Date of Drug Marketing on Disproportionality Measures in Pharmacovigilance: The Example of Suicide with SSRIs Using Data From the UK MHRA
pp. 441-447(7)
Authors: Pariente, Antoine; Daveluy, Amélie; Laribière-Bénard, Anne; Miremont-Salame, Ghada; Begaud, Bernard; Moore, Nicholas